

Cover Story
Conversation with The Cancer LetterFree
This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full list of our coverage is available here.
In Brief
Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for Nov. 2020
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Narjust Duma named associate director of the Cancer Care Equity Program at DFCI, Harvard Medical School
- Robert Stone: City of Hope aims to transform cancer care nationally through new models, partnerships
- Biden commits to creating “ARPA-H” research body in visit to Ohio State
- Amy Reed, physician and patient who “moved mountains” to end widespread use of power morcellation, dies at 44
- The Cancer Letter gets a new website
- Abecma receives FDA approval for multiple myeloma